Regulation of anoikis resistance by NADPH oxidase 4 and epidermal growth factor receptor

Hyeryeong Kim1, Jee Young Sung2, Eun-Kyung Park1

  • 1Comparative Biomedicine Research Branch, Division of Cancer Biology, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si 410-769, Korea.

British Journal of Cancer
|January 13, 2017
PubMed
Abstract

Insights

NADPH oxidase 4 (NOX4) upregulation promotes lung cancer cell survival by enhancing anoikis resistance through reactive oxygen species (ROS)-mediated epidermal growth factor receptor (EGFR) activation and maintenance. This mechanism is crucial for metastasis.

Area of Science:

  • Cell biology
  • Cancer research
  • Molecular oncology

Background:

  • Anoikis, a form of apoptosis induced by cell detachment, normally prevents metastasis.
  • Cancer cells often develop resistance to anoikis, a critical step for metastatic progression.
  • Understanding the molecular mechanisms of anoikis resistance is vital for developing effective lung cancer therapies.

Purpose of the Study:

  • To investigate the role of NADPH oxidase 4 (NOX4) and epidermal growth factor receptor (EGFR) activation in anoikis resistance in lung cancer.
  • To elucidate the underlying molecular mechanisms by which NOX4 influences anoikis resistance.

Main Methods:

  • Cultured lung cells in attached and suspended states to induce or prevent anoikis.
  • Quantified cell viability, NOX4 and EGFR expression, and reactive oxygen species (ROS) levels.
  • Utilized NOX4 knockdown and overexpression techniques to assess effects on anoikis sensitivity.
  • Examined NOX4 and EGFR levels in clinical lung cancer tissues.

Main Results:

  • NOX4 expression and ROS levels were elevated in suspended cells, activating Src and EGFR.
  • NOX4 knockdown sensitized cells to anoikis by reducing Src and EGFR activation.
  • NOX4 overexpression enhanced anoikis resistance and increased EGFR levels.
  • Clinical lung cancer tissues showed upregulated NOX4 correlating positively with EGFR levels.

Conclusions:

  • NOX4 upregulation confers anoikis resistance in lung cancer cells.
  • This resistance is mediated by ROS-dependent activation and maintenance of EGFR and Src signaling.
  • Targeting the NOX4-EGFR axis may represent a therapeutic strategy for overcoming lung cancer metastasis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.4K